Peisheng Xu
Peisheng Xu, PhD, joined AcePre as the Chief Technology Officer (CTO) in 2017. He is a Professor in the Department of Drug Discovery & Biomedical Sciences at the University of South Carolina College of Pharmacy. The primary interests of his lab are design and synthesis of biomaterials and exploring their biomedical applications. The long-term goals of his research are to develop cancer targeted nano-sized drug carrier to eradicate cancer and to design novel drug formulation to alleviate central nervous system diseases. He has been granted 17 granted US and international patents and published about 50 manuscripts in high impact journals.